Rayonier Advanced Materials (RYAM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
4 Mar, 2026Executive summary
Leadership transition and new CEO emphasized, with a renewed focus on execution, operational improvement, and disciplined capital spending.
2025 revenue was $1.5 billion, down year-over-year, with Adjusted EBITDA of $133 million and negative free cash flow of $88 million.
Operating income for 2025 was $4 million, a decrease of $35 million from 2024; Q4 operating income was $11 million, flat year-over-year.
Strategic priorities for 2026 include delivering positive free cash flow, EBITDA growth, and leadership in Cellulose Specialties.
No plans to divest or close any business segments; all are targeted for improvement.
Financial highlights
Adjusted Free Cash Flow for 2025 was negative $88 million, compared to positive $95 million in 2024.
Cellulose Specialties contributed $862 million in net sales and $228 million in Adjusted EBITDA for 2025, with a 28% EBITDA margin in Q4.
Paperboard net sales were $179 million with Adjusted EBITDA of $14 million for 2025; new products and improved plant performance drove sequential Q4 gains.
High-Yield Pulp net sales were $112 million with Adjusted EBITDA of negative $27 million for 2025; oversupply persists but new products are under customer testing.
Year-end Adjusted Net Debt was $745 million; Net Secured Debt was $715 million; total liquidity was $157 million.
Outlook and guidance
2026 focus is on delivering positive free cash flow, substantial EBITDA improvement, and value-based pricing in Cellulose Specialties.
Path to positive free cash flow in 2026 includes CapEx reduction, fixed cost savings, and new product commercialization.
2026 modeling assumptions: CapEx $80 million, cash interest expense $85 million, environmental expenditure $5 million, cash taxes $3–5 million, stock compensation $8–10 million.
Early 2026 volumes expected to be pressured as customers adjust ordering and inventory.
Ongoing updates to forward plans, with more details to be shared in future earnings calls.
Latest events from Rayonier Advanced Materials
- Board refresh, CEO change, and governance reforms highlight a focus on accountability and performance.RYAM
Proxy filing20 Mar 2026 - 2026 targets positive cash flow, EBITDA growth, and new product launches amid disciplined execution.RYAM
Gabelli Funds Annual Specialty Chemicals Symposium20 Mar 2026 - Aiming to double EBITDA by 2027, leveraging price, cost, and biomaterials growth.RYAM
17th Annual Southwest IDEAS Conference3 Feb 2026 - Transformation to specialty cellulose, innovation, and sustainability drive growth and profitability.RYAM
Fireside Chat3 Feb 2026 - Shifting to specialty cellulose and biomaterials, with debt reduction and margin expansion in focus.RYAM
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Q2 net sales and earnings surged, with 2024 guidance raised and cash flow outlook improved.RYAM
Q2 20242 Feb 2026 - Shifting to specialty cellulose and biomaterials, with asset sales and debt reduction underway.RYAM
Stifel 2024 Cross Sector Insight Conference1 Feb 2026 - Q3 net sales and Adjusted EBITDA surged, 2024 guidance held, and $700M refinancing secured.RYAM
Q3 202416 Jan 2026 - Focus on specialty cellulose, biomaterials, and debt reduction drives margin and cash flow growth.RYAM
Gabelli Funds' 16th Annual Specialty Chemicals Symposium26 Dec 2025